# Oryzon Genomics S.A. (ORYZF)

> Healthcare · ES · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/ORYZF/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | € 4.29M | € -2.78M | € 0 | € 11.94M | € 105.41M |
| 2024 | € 11.88M | € -3.60M | € 0 | € 11.20M | € 87.04M |
| 2023 | € 23.00M | € -3.64M | € 0 | € 13.69M | € 81.77M |
| 2022 | € 24.99M | € -4.70M | € 0 | € 17.44M | € 72.57M |
| 2021 | € 18.51M | € -5.56M | € 0 | € 13.77M | € 71.26M |
| 2020 | € 11.92M | € -4.26M | € 0 | € 9.09M | € 75.93M |
| 2019 | € 12.83M | € -4.60M | € 0 | € 9.48M | € 61.13M |
| 2018 | € 8.58M | € -1.49M | € 0 | € 14.83M | € 45.13M |
| 2017 | € 5.54M | € -6.67M | € 0 | € 19.49M | € 34.43M |
| 2016 | € 6.52M | € -7.09M | € 0 | € 19.18M | € 22.73M |
| 2015 | € 9.45M | € -1.31M | € 0 | € 4.47M | € 27.59M |
| 2014 | € 20.49M | € 8.77M | € 0 | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.11 |
| Liabilities / Eq | 0.25 |
| Current Ratio | 1.95 |

## Other views

- [Metrics](https://sponda.capital/en/ORYZF.md)
- [Charts](https://sponda.capital/en/ORYZF/charts.md)
- [Compare](https://sponda.capital/en/ORYZF/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.